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A B S T R A C T
This report describes a case of neurosyphilis presenting with memory disturbances, attention deﬁcit, and
acute psychotic decompensation in an immunocompetent man. Despite the known connection of
neurosyphilis with psychiatric symptoms, this cause often remains unrecognized. This report
emphasizes the importance of maintaining a suspicion for the disease in patients with vague symptoms
and describes the diagnostic difﬁculties.
© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A whole range of diseases can affect patients through neuropsy-
chiatric manifestations. Identifying the medical disease at an early
stage can be crucial because many conditions can be reversible with
appropriate and timely treatment. Processes causing neuropsychi-
atric symptoms include autoimmune, infectious, endocrine, meta-
bolic, and neoplastic diseases (Isaac and Larson, 2014).
The term neurosyphilis refers to an infection of the central
nervous system caused by the spirochete Treponema pallidum
resulting in an insidious chronic meningeal inﬂammation. Despite
the increasing incidence of the tertiary form of syphilis associated
with the increasing prevalence of HIV infection, neurosyphilis
remains uncommon in immunocompetent patients (Rodrigues
et al., 2012). However, the number of infected patients is increasing
in Eastern European countries (Brinar and Habek, 2006). The rapid
and accurate diagnosis of neurosyphilis is challenging (Rodrigues
et al., 2012); however, there are certain clinical signs and ﬁndings
that may arouse suspicion.
The aim of this report is to emphasizetheimportance of increased
protein levels in the cerebrospinal ﬂuid (CSF) and dura thickening in* Corresponding author at: Department for Functional Genomics, Center for
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dementia. These ﬁndings should raise the suspicion of neurosyphilis
and lead to further serology and CSF analysis.
Case report
A 47-year-old man presented with a 5-month history of
progressively worsening neurological symptoms that had started
as memory disturbances (especially short-term memory disturban-
ces) and attention deﬁcit. A month after the onset of symptoms, the
patient had experienced acute psychotic decompensation and
hallucinatory-paranoid events. The patient was initially misdiag-
nosed with a schizoaffective disorder and treated with antipsychotic
drugs. Psychological tests revealed deviations in terms of short-term
memory and graphomotor skill. Cognitive impairment was without
daily ﬂuctuations and was slightly more evident while the patient
was being treated with antipsychotic therapy. His speech was not
affected and he could successfully perform daily activities.
Occasionally he was depressed without anxiety or aggression.
Eight months after symptom onset, magnetic resonance
imaging (MRI) and computed tomography (CT) of the brain
revealed age-inappropriate and premature atrophic changes of the
brain parenchyma, with wide CSF spaces infra- and supratento-
rially. MRI also showed thickening of the dura and bilateral
subdural hygromas (Figure 1). Neurocognitive testing indicatediety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
agreb from ClinicalKey.com by Elsevier on March 29, 2019.
. Copyright ©2019. Elsevier Inc. All rights reserved.
Figure 1. MRI axial T2-weighted (A) and FLAIR (B) images demonstrating diffuse atrophy, bilateral lamellar subdural hygromas, and dural thickening (arrow).
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associative memory, and less severe disturbances of attention and
executive functions. Values of thyroid hormones, vitamin B12, and
folic acid were within the normal range.
Ten months after symptom onset, CSF analysis showed an
increased number of lymphocytes (67/3  106/l; normal range 15/
3  106/l) and elevated protein values (68 mg/dl; normal range 17–
37 mg/dl). The value of Tau protein in the CSF was 257 pg/ml and
the value of pTau - phosphorylated tau protein was 18 pg/ml. The
level of beta-amyloid was 762 pg/ml. Creatine kinase in the blood
was also increased (1014 U/l; normal range 0–177 U/l). Due to the
increased number of lymphocytes and elevated protein values in
the CSF with the presence of dura thickening, a serological and
neuroimmunological evaluation was performed, which revealed
neurosyphilis. The following tests were reactive: Venereal Disease
Research Laboratory/Rapid Plasma Reagin (VDRL/RPR; serum
1:128, CSF 1:4), Treponema pallidum hemagglutination (TPHA;
serum 1:20 480, CSF 1:2560), and ﬂuorescent treponemal antibody
absorption (IgG-FTA-ABS; serum 1:40, CSF poor reactive). HIV
infection was also suspected, but the patient was seronegative.
Therapy was started with a course of intravenous procaine
benzylpenicillin. The diagnosis was established 10 months after
the onset of symptoms.
The patient was hospitalized again after 3 and 11 months. CSF
analysis after 11 months revealed a decrease in lymphocyte count (2/
3  106/l) and proteinvalues (40 mg/dl). A repeated MRIexamination
after3 monthsdidnot showthepreviouslyvisiblesubdural hygroma,
and dural thickening was less prominent; however, atrophy of the
brain parenchyma was more evident, particularly in the hippocam-
pus. The cognitive impairment was still present, but there had been a
signiﬁcant improvement following antibiotic therapy. There was an
evident reduction in RPR titer, indicating a good response to therapy
(initial: serum 1:128, CSF 1:4; after 3 months: serum 1:32, CSF 1:2;
after 11 months: serum 1:8).
Discussion
This case stresses the need to include neurosyphilis in the
differential diagnosis for subjects presenting with neuropsychiat-
ric manifestations. There has recently been a drastic increase in the
incidence of syphilis (Mattei et al., 2012). Although still uncommon
in immunocompetent patients (Rodrigues et al., 2012), this factDownloaded for Anonymous User (n/a) at University Hospital Z
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suspicion, especially within the HIV-positive population.
Neurosyphilis has diverse presentations and may occur at any
stage of the disease (Mattei et al., 2012). If symptoms occur at the
beginning of the disease, the spirochete usually affects the CSF,
meninges, and blood vessels. The late variant is manifested by the
involvement of the parenchyma of the brain and spinal cord. CSF
examination is required in patients with syphilis and neurological
symptoms, as well as in patients with clinically and serologically
determined treatment failure (Mattei et al., 2012).
The non-speciﬁc clinical presentations and unclear signiﬁcance
of supportive laboratory tests make the rapid and accurate
diagnosis challenging. There are several current criteria based
on CSF antibody tests, positive serum RPR, the Treponema pallidum
particle agglutination (TPPA) test, and white blood cell count.
Neurosyphilis is suspected when the CSF white blood cell count is
higher than 20  106 cells/l or a CSF VDRL test result is reactive
(Zhang et al., 2015). Although an elevation of the CSF protein
concentration is consistent with neurosyphilis, it may be less
speciﬁc than CSF pleocytosis (Marra et al., 2008; Tso et al., 2008). In
patients with suspected neurosyphilis, a CSF lymphocyte count
>5 106 cells/l or a protein concentration >45 mg/dl is consistent
with the diagnosis of neurosyphilis (Tso et al., 2008). In patients
with HIV infection and syphilis, establishing a diagnosis of
neurosyphilis is particularly difﬁcult because HIV itself causes
mild CSF pleocytosis and a mild elevation of the CSF protein
concentration (Marra et al., 2008). If the initial examination of CSF
shows pleocytosis like in the patient presented herein, CSF analysis
should be repeated every 6 months until the number of cells
decreases to a normal value. The RPR titer can be linked to disease
activity, and a four times reduction in titer could be used as proof of
successful therapy (Saunderson and Chan, 2012), which was also
the case in the patient reported here.
There is an increasing role of neuroimaging methods in the
diagnosis of unclear dementia and psychoses. Dural thickening is a
rare disorder of diverse etiology, associated with rheumatoid
arthritis, syphilis, Wegener’s granulomatosis, tuberculosis, and
cancer (Kupersmith et al., 2004). A connection between dementia
and dural thickening has recently been established. One study
observed dural thickening on MRI in one-third of patients with
mild cognitive impairment or Alzheimer’s disease (Qureshi et al.,
2015). Neurosyphilis should also be considered as a possibleagreb from ClinicalKey.com by Elsevier on March 29, 2019.
. Copyright ©2019. Elsevier Inc. All rights reserved.
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in dural thickening (Rosa Júnior et al., 2016).
In conclusion, in the event of a relatively sudden appearance of
psychiatric and cognitive symptoms, all possible secondary causes,
including syphilis, should be excluded. This case demonstrates the
need for greater clinical and epidemiological vigilance to reduce
the morbidity and mortality associated with syphilis, especially in
patients with various neurocognitive symptoms, and also the need
to shorten the often lengthy diagnosis time.
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